Equities

Oncolys Biopharma Inc

4588:TYO

Oncolys Biopharma Inc

Actions
Health CarePharmaceuticals and Biotechnology
  • Price (JPY)789.00
  • Today's Change94.00 / 13.53%
  • Shares traded2.77m
  • 1 Year change+42.42%
  • Beta1.2625
Data delayed at least 20 minutes, as of Mar 29 2024 06:00 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Events & Activity

  • 4588:TYO price reached a new 52-week high of 781.00 at 13:51 BST
  • 4588:TYO trading volume exceeds daily average by +49.05%
  • 4588:TYO price moved over -1.13% to 614.00
  • 4588:TYO price rises above 15-day moving average to 627.00 at 09:12 BST
  • 4588:TYO price rises above 15-day moving average to 628.00 at 09:43 BST

Key statistics

Oncolys Biopharma Inc (4588:TYO) set a new 52-week high during today's trading session when it reached 794.00. Over this period, the share price is up 38.42%.
52-week range
Today
504.00Jul 12 2023794.00Mar 29 2024
Short selling activity
Low
Med
High
Provided by S&P Global Market Intelligence
Open712.00
High794.00
Low698.00
Bid785.00
Offer790.00
Previous close695.00
Average volume318.19k
Shares outstanding20.28m
Free float17.44m
P/E (TTM)--
Market cap14.10bn JPY
EPS (TTM)-108.23
JPY
Data delayed at least 20 minutes, as of Mar 29 2024 06:00 BST.
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.
S&P Global Market Intelligence Short Selling Activity © S&P Global Market Intelligence. All rights reserved.
Although S&P Global Market Intelligence has made every effort to ensure this data is correct, nevertheless no guarantee is given to the accuracy or completeness. Any opinions or estimates expressed herein are those of S&P Global Market Intelligence on the date of preparation and are subject to change without notice; however no such opinions or estimates constitute legal, investment or other advice. You must therefore seek independent legal, investment or other appropriate advice from a suitably qualified and/or authorised and regulated advisor prior to making any legal, investment or other decision. This is intended for information purposes only and is not intended as an offer or recommendation to buy, sell or otherwise deal in securities.